Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation.

Molecular Cancer
Balazs RadnaiFerenc Gallyas

Abstract

2,4-Dimethoxyphenyl-E-4-arylidene-3-isochromanone (IK11) was previously described to induce apoptotic death of A431 tumor cells. In this report, we investigated the molecular action of IK11 in the HepG2 human hepatocellular carcinoma cell line to increase our knowledge of the role of poly (ADP-ribose)-polymerase (PARP), protein kinase B/Akt and mitogen activated protein kinase (MAPK) activation in the survival and death of tumor cells and to highlight the possible role of PARP-inhibitors in co-treatments with different cytotoxic agents in cancer therapy. We found that sublethal concentrations of IK11 prevented proliferation, migration and entry of the cells into their G2 phase. At higher concentrations, IK11 induced reactive oxygen species (ROS) production, mitochondrial membrane depolarization, activation of c-Jun N-terminal kinase 2 (JNK2), and substantial loss of HepG2 cells. ROS production appeared marginal in mediating the cytotoxicity of IK11 since N-acetyl cysteine was unable to prevent it. However, the PARP inhibitor PJ34, although not a ROS scavenger, strongly inhibited both IK11-induced ROS production and cell death. JNK2 activation seemed to be a major mediator of the effect of IK11 since inhibition of JNK resulted i...Continue Reading

References

Jan 12, 2002·The Journal of Biological Chemistry·Hiroki AokiSeigo Izumo
Sep 12, 2002·Pharmacological Reviews·László Virág, Csaba Szabó
May 25, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Grazia Graziani, Csaba Szabó
Jul 1, 2006·International Journal of Biological Sciences·Joseph A De SotoChu-Xia Deng
Apr 25, 2007·Apoptosis : an International Journal on Programmed Cell Death·Stefan Grimm, Dieter Brdiczka
May 12, 2009·Biochemical Pharmacology·Arpad SzantoGabor Varbiro
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Andrea RasolaPaolo Bernardi
Feb 11, 2010·Toxicon : Official Journal of the International Society on Toxinology·Ying-Jung ChenLong-Sen Chang
Sep 9, 2010·Expert Reviews in Molecular Medicine·Brian LeberDavid W Andrews
Aug 9, 2011·Biochemical and Biophysical Research Communications·Shuai WangZhi-Xiang Xu

❮ Previous
Next ❯

Citations

Oct 29, 2017·Molecular Cancer·Manmei LongJian Wang
Aug 28, 2021·Biomedicines·Abdullah AlhusainiNiamh Lynam-Lennon

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
electrophoresis
flow
FCS
FACS
flow cytometry

Software Mentioned

Cellquest
Image J

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.